Health-related quality of life in patients with multiple myeloma treated in the phase 3 ATLAS trial of post-transplant maintenance with carfilzomib, lenalidomide, and dexamethasone or lenalidomide alone.

Details

Language :

English

ISSN :

00323772

Volume :

134

Issue :

5

Database :

Supplemental Index

Journal :

Polish Archives of Internal Medicine

Publication Type :

Academic Journal

Accession number :

178199871

Full Text :

https://doi.org/10.20452/pamw.16749